Deep phenotyping brings accuracy to precision medicine

Biotech companies are leveraging the wealth of omics and imaging data to study deep phenotypes for a range of clinical applications including precision medicine approaches to liver disease, neurodegenerative disorders and infertility.

Related Keywords

Luxembourg ,United Kingdom ,British ,Mylene Yao ,Jens Schwamborn ,Vyant Bio , ,Ochre Bio ,